
Impact of Clinical Pharmacists in Inflammatory Bowel Disease Centers During the COVID-19 Pandemic
Author(s) -
Shubha Bhat,
Francis A. Farraye,
Alan C. Moss
Publication year - 2020
Publication title -
the american journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.907
H-Index - 252
eISSN - 1572-0241
pISSN - 0002-9270
DOI - 10.14309/ajg.0000000000000787
Subject(s) - medicine , inflammatory bowel disease , pandemic , pharmacist , clinical pharmacy , covid-19 , audit , disease , intensive care medicine , clinical audit , pharmacy , family medicine , infectious disease (medical specialty) , management , economics
To characterize the clinical pharmacists' impact on caring for patients with inflammatory bowel disease during COVID-19.